Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis

BACKGROUND: Type 2 diabetes and obesity, as states of chronic inflammation, are risk factors for severe COVID-19. Metformin has cytokine-reducing and sex-specific immunomodulatory effects. Our aim was to identify whether metformin reduced COVID-19-related mortality and whether sex-specific interacti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet Healthy Longev
Main Authors: Bramante, Carolyn T, Ingraham, Nicholas E, Murray, Thomas A, Marmor, Schelomo, Hovertsen, Shane, Gronski, Jessica, McNeil, Chace, Feng, Ruoying, Guzman, Gabriel, Abdelwahab, Nermine, King, Samantha, Tamariz, Leonardo, Meehan, Thomas, Pendleton, Kathryn M, Benson, Bradley, Vojta, Deneen, Tignanelli, Christopher J
Formato: Artigo
Idioma:Inglês
Publicado em: The Author(s). Published by Elsevier Ltd. 2021
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7832552/
https://ncbi.nlm.nih.gov/pubmed/33521772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2666-7568(20)30033-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados